VivoSim Labs, INC. (VIVS) Form 8-K — Oct 6, 2026
VivoSim Labs held its 2026 Annual Meeting on September 30, 2026, with stockholders approving six proposals including a board-discretionary reverse stock split at a ratio between 1-to-5 and 1-to-20, exercisable any time before September 30, 2027. Stockholders also approved increasing the 2022 Equity Incentive Plan reserve by 3,165,000 shares and, under Nasdaq Listing Rule 5635(d), the issuance of 4,705,883 shares upon exercise of July 2026 private placement warrants. Notably, the private placement approval also included cutting the exercise price of May 2024 warrants from $9.60 to $0.85 per share — a substantial price concession suggesting the original warrants were deeply out of the money.
Key figures
- Quorum
- 6,180,635 of 16,586,495 shares (37.26%)
- Say on pay
- 76.33% of votes cast
- Plan approval
- 72.52% of votes cast
- Auditor ratified
- 92.51% of votes cast
- Reverse split ratio
- 1:5 to 1:20 (board discretion, before September 30, 2027)
- Warrant reprice new
- $0.85
- Warrant reprice old
- $9.60
- Reverse split approval
- 74.12% of votes cast
- Equity plan share increase
- 3165000
- Private placement approval
- 77.87% of votes cast
- Private placement warrant shares
- 4705883
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.